Earl T Markley, Cooil Bruce, Rubin Josh E, Chari Ravi S
Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University, Nashville, TN 37232-4753, USA.
Transplantation. 2008 Jul 27;86(2):238-44. doi: 10.1097/TP.0b013e3181778d54.
Liver transplantation is a costly procedure and its cost is likely driven by both donor and recipient factors. Recently, the recipient model for end-stage liver disease (MELD) score has been correlated with increased posttransplant cost; however, other factors have not been identified. We sought to identify if other donor and recipient factors are associated with increased cost.
One hundred sixty-six liver transplants performed at our center from January 2004 through February 2006 were included in the estimation sample, and the subsequent 75 transplants were used as a validation cohort. To determine whether donor factors influenced cost, two latent class linear regression models were created from the estimation sample: one considering only recipient variables (model A) and a second incorporating both donor and recipient factors (model B). The resultant models were then validated in the second group of patients and compared with the best single-segment linear regression models.
Model A predictors include pretransplant intensive care unit (ICU) stay, age x body mass index, and calculated MELD. In model B, significant predictors are calculated MELD, age, age x pretransplant ICU stay, and donor age more than 40 as significant variables. In validation, only model A remained predictive of cost.
Although marginal donor factors are recognized to influence clinical outcome, they did not factor significantly in cost modeling. In addition to MELD, the recipient factors of pretransplant ICU stay, age, and body mass index are pretransplant variables correlated mostly with posttransplant cost across broad populations.
肝移植是一项成本高昂的手术,其费用可能由供体和受体因素共同驱动。最近,终末期肝病模型(MELD)评分与移植后成本增加相关;然而,其他因素尚未明确。我们试图确定其他供体和受体因素是否与成本增加有关。
将2004年1月至2006年2月在我们中心进行的166例肝移植纳入估计样本,随后的75例移植用作验证队列。为了确定供体因素是否影响成本,从估计样本中创建了两个潜在类别线性回归模型:一个仅考虑受体变量(模型A),另一个纳入供体和受体因素(模型B)。然后在第二组患者中对所得模型进行验证,并与最佳单段线性回归模型进行比较。
模型A的预测因素包括移植前重症监护病房(ICU)住院时间、年龄×体重指数和计算得出的MELD。在模型B中,显著的预测因素是计算得出的MELD、年龄、年龄×移植前ICU住院时间以及供体年龄大于40岁作为显著变量。在验证中,只有模型A仍然能够预测成本。
虽然边缘供体因素被认为会影响临床结果,但它们在成本建模中并未起到显著作用。除了MELD之外,移植前ICU住院时间、年龄和体重指数等受体因素是广泛人群中与移植后成本最相关的移植前变量。